Navigation Links
Not your average heat shield
Date:3/26/2012

WASHINGTON, March 26In a new approach to invisibility cloaking, a team of French researchers has proposed isolating or cloaking objects from sources of heatessentially "thermal cloaking." This method, which the researchers describe in the Optical Society's (OSA) open-access journal Optics Express, taps into some of the same principles as optical cloaking and may lead to novel ways to control heat in electronics and, on an even larger scale, might someday prove useful for spacecraft and solar technologies.

Recent advances in invisibility cloaks are based on the physics of transformation optics, which involves metamaterials and bending light so that it propagates around a space rather than through it. Sebastien Guenneau, affiliated with both the University of Aix-Marseille and France's Centre National de la Recherche Scientifique (CRNS), decided to investigate, with CRNS colleagues, whether a similar approach might be possible for thermal diffusion.

"Our key goal with this research was to control the way heat diffuses in a manner similar to those that have already been achieved for waves, such as light waves or sound waves, by using the tools of transformation optics," says Guenneau.

Though this technology uses the same fundamental theories as recent advances in optical cloaking, there is a key difference. Until now, he explains, cloaking research has revolved around manipulating trajectories of waves. These include electromagnetic (light), pressure (sound), elastodynamic (seismic), and hydrodynamic (ocean) waves. The biggest difference in their study of heat, he points out, is that the physical phenomenon involved is diffusion, not wave propagation.

"Heat isn't a waveit simply diffuses from hot to cold regions," Guenneau says. "The mathematics and physics at play are much different. For instance, a wave can travel long distances with l
'/>"/>

Contact: Sarah Cogan
scogan@osa.org
202-416-1409
Optical Society of America
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
2. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
3. SleepQuest Compliance Again Doubles Industry Average
4. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
5. Agendia Signs Contract with Blue Shield of California
6. Minimally Invasive Devices, Inc. Announces Release of FloShield™ PLUS
7. Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10
8. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
9. TCT 2009 to Feature vProtect(TM) Luminal Shield, a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical
10. vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque
11. SyntheMed Announces FDA Clearance of SinusShield(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Not your average heat shield
(Date:7/25/2014)... Pittsburgh, PA (PRWEB) July 25, 2014 ... annual Call for Topics for Conferee Networking. These two-hour ... similar interests to meet and resolve problems, discuss new ... , The deadline to submit a topic for consideration ... at pittcon.org . The Conferee Networking committee will ...
(Date:7/25/2014)... BENSALEM, Pa. , July 25, 2014 /PRNewswire-iReach/ ... services and consulting for global corporations operating in ... will host its first annual Global User Group ... in historic Philadelphia, Pennsylvania ... Photo - http://photos.prnewswire.com/prnh/20140724/130263 ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... Calif. , July 24, 2014  Now available ... to home. Rehealth Regenerative Therapies , located in ... and other physically active people a new health option: ... Regardless of age, countless patients suffer from joint ... activities, such as muscle tears, torn rotator cuff, tennis ...
Breaking Biology Technology:Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3
... , , Mark Churchill and Mark Harrison, Thermo Finnigan, , ... , , Bioanalytical Method Validation , ... using , a Thermo Finnigan TSQ Quantum mass spectrometer, , ... , , , , Guidelines on Bioanalytical ...
... , , , , , , ... Beecham Pharmaceuticals , , Metabolite ... Finnigan LCQ , Series of ion trap mass spectrometers. , ... , An integral part of the process by ...
... , , , , Jack Cunniff, Philip Tiller, Michael Harvey, ... , , , , , ... using the Thermo Finnigan LCQ , Series of ion trap mass spectrometers. , ... , For more than five thousand years tea has been used in ...
Cached Biology Technology:Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine , in Bovine Plasma using the TSQ Quantum Mass Spectrometer 2Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine , in Bovine Plasma using the TSQ Quantum Mass Spectrometer 3Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine , in Bovine Plasma using the TSQ Quantum Mass Spectrometer 4Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine , in Bovine Plasma using the TSQ Quantum Mass Spectrometer 5Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine , in Bovine Plasma using the TSQ Quantum Mass Spectrometer 6In-Vitro Metabolism Studies Using Data-Dependent LC/MSn 2In-Vitro Metabolism Studies Using Data-Dependent LC/MSn 3In-Vitro Metabolism Studies Using Data-Dependent LC/MSn 4In-Vitro Metabolism Studies Using Data-Dependent LC/MSn 5In-Vitro Metabolism Studies Using Data-Dependent LC/MSn 6Structural Determination of Flavonoids Using MSn 2Structural Determination of Flavonoids Using MSn 3Structural Determination of Flavonoids Using MSn 4
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
... what they want, to paraphrase the Rolling Stones, but sometimes ... that will appear in the May issue of the ... broad sweep of evolutionary changes in life on earth as ... shifts. And yet the amount of variability seen among successive ...
... ,PORTLAND, Ore. April 2, 2010. Countless studies and reports exist ... is the impact on the soil? Should one leave the ... offsite in preparation for replanting the area in the future? ... possible, that the debris remaining on the ground after logging ...
... (ACMGF) has awarded Dr. Marilyn M. Li, of the ... Medicine the 2010-2011 Luminex/ACMGF Award at the ACMG 2010 ... includes a $100,000 grant and is aimed at the ... including the development of research guidelines. "Medical ...
Cached Biology News:Ecologists receive mixed news from fossil record 2Study reveals that logging debris suppresses development of an invasive competitor, Scotch broom 2Dr. Marilyn M. Li, M.D., FACMG, is the 2010 Luminex/ACMGF award recipient 2
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Antibeta-lactoglobulin monoclonal antibody(CD-2)...
MAb to Vasopressin Preservative: NaN3...
Biology Products: